The Latest Cardiac and Vascular News
Go-to-Market Strategy in U.S. to Optimize Provider Engagement and Drive Demand for VASCEPA® European Expansion Strategy On Track with Reimbursement Negotiations and Launch Preparations for VAZKEPA Underway in Multiple Markets Plans for Regulatory Filings for Approval of VASCEPA in Several Additional Countries in 2022 Company to Host Conference Call Today at […]
Company to Advance its Next Generation Percutaneous Ventricular Assist Device LOS GATOS, Calif., Feb. 28, 2022 /PRNewswire/ — Supira Medical, Inc., a Shifamed portfolio company that is focused on developing a next-generation solution for temporary mechanical circulatory support, announced today the closing of $30M in Series C financing. Led by Cormorant Asset Management and The […]
2021 HIGHLIGHTS compared to 2020: — Annual revenues increased by 37% — Net income increased by 23% — Cash at December 31, 2021 increased to $37.3 million from $22.1 million SANTA CLARA, Calif., Feb. 28, 2022 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical […]
TEL AVIV, Israel, Feb. 28, 2022 /PRNewswire/ — The Israeli digital health company CVAid Medical, which has developed a platform based on artificial intelligence for diagnosing and treating cerebrovascular accidents (CVAs, or strokes), has announced the completion of capital raising from Philips together with Sanara Capital. The Israeli Rad Biomed investment fund led […]
SUNNYVALE, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2021. “Our team and physicians had a tremendous impact […]
BURLINGTON, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) — LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2021 results, announced a $0.125/share quarterly dividend (+14%) and provided guidance. Q4 2021 Financial Results Sales of $39.5mm, +5% (+6% organic) vs. Q4 2020 Op. income of $8.3mm, -13% Op. margin […]
Commercial Launch Readiness Activities Underway for Omecamtiv Mecarbil in Advance of PDUFA Date of November 30, 2022 SEQUOIA-HCM Open to Enrollment; Development Program for Aficamten Expanding in 2022 Company Provides 2022 Financial Guidance; More Than 2 Years of Cash Runway SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Cytokinetics, […]
MEMPHIS, Tenn., Feb. 25, 2022 (GLOBE NEWSWIRE) — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease (PAD), expands its footprint with its newest clinic at 5645 Murray Ave., in Memphis. Board-Certified Vascular and interventional Radiologist, Samuel G. Putnam III, MD, FSIR, will manage the new clinic. […]
Q4 2021 reported revenue of $278.5 million, up 7.9% on a reported basis and up 8.4% on a constant currency revenue, organic* basis, compared to Q4 2020 Q4 2021 GAAP EPS increased 32% year-over-year to $0.36, compared to $0.27 in Q4 2020 Q4 2021 non-GAAP EPS* increased 31% year-over-year to […]
PRAIRIE VILLAGE, Kan., Feb. 24, 2022 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the hiring of Dan Tamez as Senior Director of Nonclinical and Clinical Research and the engagement of Geoff Tansley, PhD as Senior R&D Consultant. Tamez will lead nonclinical […]
